Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0.69%10.51B | -2.60%10.43B | -8.13%2.5B | -3.21%2.64B | -0.40%2.73B | 1.64%2.56B | 12.63%10.71B | 15.44%2.72B | 16.02%2.73B | 9.68%2.74B |
| Cost of revenue | -1.28%7.58B | -3.66%7.68B | -7.28%1.88B | -2.92%1.96B | -3.51%1.98B | -0.67%1.85B | 8.29%7.97B | 5.19%2.03B | 11.81%2.02B | 9.81%2.05B |
| Gross profit | 6.18%2.92B | 0.49%2.75B | -10.65%611.31M | -4.04%680.37M | 8.85%750.66M | 8.21%710.13M | 27.54%2.74B | 62.47%684.2M | 30.01%709.05M | 9.31%689.62M |
| Operating expense | 26.23%1.88B | 7.33%1.49B | 2.17%338.73M | 18.24%383.47M | 13.20%435.89M | -4.41%333M | 2.72%1.39B | -9.69%331.52M | 4.72%324.31M | 8.01%385.06M |
| Operating profit | -17.52%1.04B | -6.56%1.26B | -22.71%272.58M | -22.83%296.91M | 3.35%314.77M | 22.48%377.14M | 69.73%1.35B | 552.82%352.68M | 63.26%384.74M | 11.01%304.57M |
| Net non-operating interest income (expenses) | 30.99%-18.53M | 28.51%-26.85M | 17.91%-5.75M | 35.25%-5.12M | 28.13%-8.02M | 30.70%-7.97M | 22.69%-37.56M | 42.87%-7M | 29.85%-7.91M | 9.60%-11.16M |
| Non-operating interest income | -19.74%6.41M | 38.67%7.99M | -38.16%1.76M | 47.59%3.74M | 396.39%963K | 723.24%1.52M | 391.55%5.76M | 641.15%2.85M | 751.01%2.54M | -49.21%194K |
| Non-operating interest expense | -28.41%24.94M | -19.58%34.84M | -23.77%7.51M | -15.14%8.87M | -20.88%8.98M | -18.76%9.49M | -12.93%43.32M | -22.08%9.85M | -9.75%10.45M | -10.79%11.35M |
| Net investment income | -110.93%-18.49M | 17.26%169.12M | 538.51%56.26M | 64.79%-32.49M | -53.52%60.19M | -28.93%85.16M | 55.22%144.23M | -124.30%-12.83M | -407.85%-92.29M | 1,470.96%129.51M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | 0 | -100.51%-65K | 0 | 0 | |||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 92.26%-1.08M | -58.06%-14M | 96.10%-544K | -96.63%142K | 0 | -46,793.10%-13.6M | -1,288.40%-8.86M | -2,271.26%-13.94M | 1,608.10%4.22M | 212.02%895K |
| Less:Other special charges | -92.26%1.08M | 58.06%14M | -96.10%544K | 96.63%-142K | --0 | 46,793.10%13.6M | 1,288.40%8.86M | 2,271.26%13.94M | -1,608.10%-4.22M | -212.02%-895K |
| Other non-operating income (expenses) | 11,534.42%25.01M | -99.66%215K | -183.67%-31.26M | -44.08%3.35M | 3.28%6.58M | 66.51%21.54M | 36.82%62.65M | 874.33%37.36M | -50.57%5.98M | 3.59%6.38M |
| Income before tax | -26.08%1.03B | -7.97%1.39B | -18.24%291.29M | -10.84%262.78M | -13.16%373.53M | 7.72%462.28M | 68.27%1.51B | 258.27%356.26M | 6.50%294.74M | 55.85%430.12M |
| Income tax | -25.56%318.35M | 27.46%427.63M | 60.03%106.76M | -10.36%71.58M | 53.49%130.07M | 14.41%119.22M | 25.43%335.5M | -12.17%66.71M | 103.72%79.85M | 60.94%84.74M |
| Net income | -26.32%709.01M | -18.09%962.25M | -36.27%184.54M | -11.03%191.2M | -29.51%243.45M | 5.57%343.06M | 86.46%1.17B | 1,132.91%289.55M | -9.54%214.89M | 54.65%345.38M |
| Net income continuous operations | -26.32%709.01M | -18.09%962.25M | -36.27%184.54M | -11.03%191.2M | -29.51%243.45M | 5.57%343.06M | 86.46%1.17B | 1,132.92%289.55M | -9.54%214.89M | 54.65%345.38M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -26.32%709.01M | -18.09%962.25M | -36.27%184.54M | -11.03%191.2M | -29.51%243.45M | 5.57%343.06M | 86.46%1.17B | 1,132.91%289.55M | -9.54%214.89M | 54.65%345.38M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -26.32%709.01M | -18.09%962.25M | -36.27%184.54M | -11.03%191.2M | -29.51%243.45M | 5.57%343.06M | 86.46%1.17B | 1,132.91%289.55M | -9.54%214.89M | 54.65%345.38M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.75%104.942 | -14.61%141.336 | -32.77%27.396 | -6.00%28.412 | -25.83%36.072 | 7.72%49.456 | 91.43%165.526 | 936.95%40.752 | -8.70%30.226 | 61.03%48.636 |
| Diluted earnings per share | -25.75%104.942 | -14.61%141.336 | -32.92%27.3373 | -6.30%28.3223 | -25.83%36.072 | 7.72%49.456 | 91.43%165.526 | 1,128.17%40.7504 | -8.70%30.226 | 61.03%48.636 |
| Dividend per share | 20.69%35 | 141.67%29 | 141.67%29 | 0 | 0 | 0 | 100.00%12 | 100.00%12 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |